TrialCancer prevention research (Philadelphia, Pa.)2011

EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia.

Wei Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.